Kraig Biocraft Laboratories Successfully Completes Recombinant Cocoon Production From Spring Trials
ANN ARBOR, Mich., April 22, 2024 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“the Company” or “Kraig Labs”), announces today what it considers to be a major milestone. The Company has completed rearing of the first generation of its new BAM-1 parental strains as part of its spring production trial. Kraig Labs has successfully produced cocoon at rates that exceeded all expectations and control parameters for these trials.
Related news for (KBLB)
- Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Nature’s Toughest Fiber
- Palisade’s Blockbuster Raise and Kraig’s Next-Gen Textiles Light Up the Morning
- Innovation Threads Drive Microcap Momentum
- Sportswear and Smart Textiles are likely Key Spider Silk Target Markets for Kraig Labs
- Bitcoin, Biotech, and Biosteel: Innovation Powers the Opening Bell